Looking to publish in Jaids-journal Of Acquired Immune Deficiency Syndromes? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowJAIDS Journal of Acquired Immune Deficiency Syndromes is a journal focused on HIV/AIDS and related research. It publishes 12 issues per year and lists an Impact Factor of 2.2. The journal highlights clinical science, epidemiology, prevention research, implementation science, critical reviews, letters to the editor, and supplements, and it offers an open access publishing option.
Looking to publish in Jaids-journal Of Acquired Immune Deficiency Syndromes? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Jaids-journal Of Acquired Immune Deficiency Syndromes accepts the following article types. Click on an article type to view submission instructions.
Basic Science
Clinical Science
Translational Research
Epidemiology
Implementation Science
Prevention Research
Critical Review
Original Articles
Rapid Communications
Brief Reports
Letters To The Editor
Recent Publications
Incidence and Risk Factors for Non-AIDS Comorbidities Following COVID-19 in People Living with HIV in Atlanta, Georgia
Cecilia Castellano, Caitlin A. Moran, Minh T. Nguyen, Vijay Ramesh, Cecile D. Lahiri
Sustainability of the Effects of Linkage Case Management on Posthospitalization HIV Outcomes: The Daraja Randomized Clinical Trial
Megan Willkens, Benson Issarow, Godfrey A. Kisigo, Severin Kabakama, Elialilia Okello, Thomas Rutachunzibwa, Derick Deogratias, Daniel W. Fitzgerald, Philip Ayieko, Myung Hee Lee, Lisa R. Metsch, Sean M. Murphy, Saidi Kapiga, Robert N. Peck
Pre-ART platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio and the risk of non-AIDS-events, AIDS-events and mortality in people with HIV
Paola Saltini, Alessandro Cozzi-Lepri, Giorgio Bozzi, Alessandro Tavelli, Giulia Marchetti, Lucia Taramasso, Sara Mazzanti, Viviana Rizzo, Andrea Antinori, Cristina Mussini, Andrea Gori, Antonella d'Arminio Monforte, Alessandra Bandera
Epidemiological impact of prioritising long-acting injectable cabotegravir to MSM with low PrEP use adherence in the Netherlands: A mathematical modelling study
Haoyi Wang, Kai J. Jonas, David van de Vijver
Evaluating Time-Space Methodologies to Detect Clusters of HIV Transmission: a Comparison of Advanced Methods in Washington State, 2010-2022
Steven Erly, Hao Yan, Roxanne P Kerani, Yajun Mei, Sarah Holte
Frequently asked questions
How long does it take to publish?
Rapid Communications will normally be published within 8 weeks of acceptance. The editorial office will acknowledge receipt of the manuscript via e-mail. Authors reviewing Rapid Communications proofs are expected to return corrections within 24 hours of receipt.
Reformat to Jaids-journal Of Acquired Immune Deficiency Syndromes using Livewrite PremiumIs a cover letter required?
A cover letter is requested for Rapid Communications to explain why the paper merits special attention.
Reformat to Jaids-journal Of Acquired Immune Deficiency Syndromes using Livewrite PremiumWhat are the publication costs?
Hybrid open access is available with an APC charged on acceptance and payable within 30 days. Eligible corresponding authors at participating institutions may receive a $0.00 APC under read-and-publish agreements.
Reformat to Jaids-journal Of Acquired Immune Deficiency Syndromes using Livewrite Premium